Literature DB >> 18539042

Heart transplantation in patients with liver cirrhosis.

Ron-Bin Hsu1, Chung-I Chang, Fang-Yue Lin, Nai-Kuan Chou, Nai-Hsin Chi, Shoei-Shen Wang, Shu-Hsun Chu.   

Abstract

OBJECTIVE: Liver cirrhosis is considered to be a contraindication to heart transplantation. However, the clinical outcome of heart transplantation in patients with liver cirrhosis has not been reported. Here, we sought to evaluate the clinical outcome of heart transplantation in cirrhotic patients.
METHODS: Data were collected by retrospective chart review. Patients with liver cirrhosis at the time of transplantation were included.
RESULTS: Between 1987 and 2007, 12 patients with liver cirrhosis underwent heart transplantation at the authors' hospital. Diagnosis of liver cirrhosis was based on preoperative abdominal sonography in five, autopsy in five, and laparotomy in two patients. Causes of heart failure were dilated cardiomyopathy in four, coronary artery disease in three, congenital heart disease in three and valvular heart disease in two patients. Causes of liver cirrhosis were alcoholism in two, cardiac in seven, and unknown in three patients. The Child classification was class A in three, class B in five and class C in four patients. Overall, the hospital mortality rate was 50% and major in-hospital complications occurred in nine patients (75%). Patients with non-cardiomyopathy diagnosis, previous sternotomy, and massive ascites had a high hospital mortality rate. The median follow-up duration was 33.5 months. There was no late death. Late post-transplant complications occurred in four patients and there was no event of liver dysfunction. All survivors were in Child class A at outpatient follow-up.
CONCLUSIONS: Although there was high mortality and morbidity, patients with end-stage heart failure and liver cirrhosis can be considered for heart transplantation with careful case selection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18539042     DOI: 10.1016/j.ejcts.2008.05.003

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

Review 1.  Congenital heart disease-associated liver disease: a narrative review.

Authors:  Florian P Reiter; Nino J Hadjamu; Nicole Nagdyman; Reinhart Zachoval; Julia Mayerle; Enrico N De Toni; Harald Kaemmerer; Gerald Denk
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

2.  Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction.

Authors:  Aalap Chokshi; Faisal H Cheema; Kenneth J Schaefle; Jeffrey Jiang; Elias Collado; Khurram Shahzad; Tuba Khawaja; Maryjane Farr; Hiroo Takayama; Yoshifumi Naka; Donna M Mancini; P Christian Schulze
Journal:  J Heart Lung Transplant       Date:  2012-03-27       Impact factor: 10.247

3.  Increased serum Wisteria floribunda agglutinin positive Mac-2 binding protein (Mac-2 binding protein glycosylation isomer) in chronic heart failure: a pilot study.

Authors:  Atsushi Okada; Hideaki Kanzaki; Yasuhiro Hamatani; Seiji Takashio; Hiroyuki Takahama; Makoto Amaki; Takuya Hasegawa; Yasuo Sugano; Satoshi Yasuda; Toshihisa Anzai
Journal:  Heart Vessels       Date:  2017-11-02       Impact factor: 2.037

4.  The liver in heart failure: a biopsy and explant series of the histopathologic and laboratory findings with a particular focus on pre-cardiac transplant evaluation.

Authors:  Christine Y Louie; Michael X Pham; Tami J Daugherty; Neeraja Kambham; John P T Higgins
Journal:  Mod Pathol       Date:  2015-03-20       Impact factor: 7.842

5.  Association of Cirrhosis and Cardiomyopathy.

Authors:  Burcu Sezgin; Cigdem Cindoglu; Ahmet Uyanikoglu; Necati Yenice
Journal:  Euroasian J Hepatogastroenterol       Date:  2019 Jan-Jun

Review 6.  Congestive Hepatopathy.

Authors:  José Ignacio Fortea; Ángela Puente; Antonio Cuadrado; Patricia Huelin; Raúl Pellón; Francisco José González Sánchez; Marta Mayorga; María Luisa Cagigal; Inés García Carrera; Marina Cobreros; Javier Crespo; Emilio Fábrega
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

7.  Adult Combined Heart-Liver Transplantation: The United States Experience.

Authors:  Sophoclis P Alexopoulos; W Kelly Wu; Ioannis A Ziogas; Lea K Matsuoka; Muhammad A Rauf; Manhal Izzy; Roman Perri; Kelly H Schlendorf; Jonathan N Menachem; Ashish S Shah
Journal:  Transpl Int       Date:  2022-01-04       Impact factor: 3.782

8.  Pulmonary Arterial Hypertension and Consecutive Right Heart Failure Lead to Liver Fibrosis.

Authors:  Florian Hamberger; Ekaterina Legchenko; Philippe Chouvarine; Young Seon Mederacke; Richard Taubert; Martin Meier; Danny Jonigk; Georg Hansmann; Ingmar Mederacke
Journal:  Front Cardiovasc Med       Date:  2022-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.